Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02395003 · ClinicalTrials.gov registry record

Study to Investigate Adipocyte Cell and Lipid Turnover in Obese Adolescents

A clinical trial, sponsored by Yale University.

Completed
Registry status
26
Enrollment target

NCT02395003 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 26 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02395003 has completed, sponsored by Yale University.

COMPLETED
Registry status
26 participants
Enrollment target

Study Summary

Insulin Resistance is the best predictor of whether the obese adolescent will develop type 2 diabetes. The present studies will focus on determining what might cause fat to accumulate in the subcutaneous fat regions and lead to local inflammation, causing insulin resistance to develop in obese adolescents.

Interventions

  • OTHER Palmitate Diet

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2016-04
Est. Completion 2023-03-07

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT02395003

The ClinicalTrials.gov registry entry for NCT02395003 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Palmitate Diet is the first listed.

NCT02395003 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02395003 about?

NCT02395003 is a clinical study titled "Study to Investigate Adipocyte Cell and Lipid Turnover in Obese Adolescents". Insulin Resistance is the best predictor of whether the obese adolescent will develop type 2 diabetes. The present studies will focus on determining what might cause fat to accumulate in the subcutaneous fat regions and lead to local inflammation, causing insulin resistance to develop in obese adole...

What is the current status of trial NCT02395003?

This trial is currently completed. The enrollment target is 26 participants. The study started on 2016-04. Estimated completion is 2023-03-07.

What interventions are being tested in trial NCT02395003?

The interventions under investigation include: Palmitate Diet (OTHER).

Who is sponsoring clinical trial NCT02395003?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.